News Janssen celebrates positive results for JNJ-2113 in psoriasi... Janssen, a Johnson & Johnson company,
Views & Analysis Patient Insights: Severe psoriasis & eczema Howard Chang has lived with severe psoriasis and atopic dermatitis for almost 40 years since childhood.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
